Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

7 Isn’t Lucky for the Dow’s Streak: Alcoa Inc (AA), Dole Food Company, Inc. (DOLE), Spectrum Pharmaceuticals, Inc. (SPPI)

Is It The Time to Buy Alcoa (AA)?After six straight record highs for the Dow Jones Industrial Average 2 Minute (Dow Jones Indices:.DJI), the market finally looks like it’s running out of steam. Even though positive data on U.S. retail sales showed a continuing willingness among American consumers to keep spending, nearly half of the 1.1% increase came from the impact of gasoline, which has seen prices rise substantially so far this year. Perhaps more importantly, after such a long run of strong performance, investors might simply be taking a break. By 10:45 a.m. EDT, the Dow was down a modest 14 points, with broader markets also falling slightly.

Alcoa Inc (NYSE:AA) is one of the biggest losers in the Dow, falling about 1%. The aluminum giant didn’t have any company-specific news to explain the move, but weakness in international stock markets points to the macroeconomic fears of sluggish growth in emerging-market countries and the potential for an even worse recession in Europe. Until global markets start to rebound more convincingly, it’ll be hard for Alcoa Inc (NYSE:AA) to expect better conditions in the aluminum market.

Elsewhere, Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) plunged more than 36% following warnings that its lead product Fusilev is finally seeing sales succumb to generic competition. Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) enjoyed a long run of strong sales due to shortages of leucovorin, the generic version of the drug, but now Spectrum Pharmaceuticals, Inc. (NASDAQ:SPPI) says the good times may be coming to a halt as hospitals and other customers find new supplies of the generic and cutt back on more expensive Fusilev.

Finally, Dole Food Company, Inc. (NYSE:DOLE) fell 7.3% after posting a worse-than-expected loss and falling well short of analysts’ sales estimates. The company cited “banana market conditions” for the decline, but the key for the company going forward is how it will adjust to the sale of its packaged-foods and Asian fresh-fruit business units to Itochu. With much lower debt after the sale, Dole Food Company, Inc. (NYSE:DOLE) needs to demonstrate that the strategic move wasn’t a mistake.

The article 7 Isn’t Lucky for the Dow’s Streak originally appeared on Fool.com and is written by Dan Caplinger.

Fool contributor Dan Caplinger has no position in any stocks mentioned. You can follow him on Twitter @DanCaplinger. The Motley Fool has no position in any of the stocks mentioned.

Copyright © 1995 – 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Loading Comments...